Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Depreciation & Amortization - Total (2019 - 2024)

Historic Depreciation & Amortization - Total for Nephros (NEPH) over the last 11 years, with Q1 2024 value amounting to $1000.0.

  • Nephros' Depreciation & Amortization - Total changed 0.0% to $1000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $1000.0, marking a year-over-year decrease of 6666.67%. This contributed to the annual value of $3000.0 for FY2023, which is 8636.36% down from last year.
  • Per Nephros' latest filing, its Depreciation & Amortization - Total stood at $1000.0 for Q1 2024, which was down 0.0% from $1000.0 recorded in Q3 2023.
  • In the past 5 years, Nephros' Depreciation & Amortization - Total ranged from a high of $12000.0 in Q2 2022 and a low of -$5000.0 during Q4 2021
  • Its 4-year average for Depreciation & Amortization - Total is $3272.7, with a median of $3000.0 in 2022.
  • As far as peak fluctuations go, Nephros' Depreciation & Amortization - Total skyrocketed by 16000.0% in 2022, and later tumbled by 9166.67% in 2023.
  • Over the past 4 years, Nephros' Depreciation & Amortization - Total (Quarter) stood at -$5000.0 in 2021, then surged by 160.0% to $3000.0 in 2022, then tumbled by 66.67% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
  • Its last three reported values are $1000.0 in Q1 2024, $1000.0 for Q3 2023, and $1000.0 during Q2 2023.